Mitral valve prolapse in systemic lupus erythematosus patients: Clinical and immunological aspects

Lupus

Volumn 12, Issue 4, 2003, Pages 308-311

  Evangelopoulos, M E ^a   Alevizaki, M ^a,b   Toumanidis, S ^a   Sotou, D ^a   Evangelopoulos, C D ^a   Koutras, D A ^a,b   Stamatelopoulos, S F ^a   Mavrikakis, M ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoimmune thyroid disease; Autoimmunity; Mitral valve prolapse; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; THYROID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE SPECIFICITY;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE; PREVALENCE; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0037270277     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu314oa     Document Type: Article

References (37)

1. Devereux R, Perloff J, Reichnek N, Josephson M. Mitral valve prolapse. Circulation 1976; 54: 3-14.
2. Boudoulas H, Kolibash A, Baker P, King B, Wooley C. Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and the pathogenesis of symptoms. Am Heart J 1989; 118: 796-818.
3. Perloff J, Child J, Edwards J. New guidelines for the clinical diagnosis of mitral valve prolapse. Am J Cardiol 1986; 57: 1124-1126.
4. Cheng TO. Mitral valve prolapse. A Rev Med 1989; 40: 201-211.
5. Nishimura RA, McGoon MD. Perspectives on mitral valve prolapse. New Engl J Med 1999; 341: 48-50.
6. Barzizza F, Venco A, Grandi AM, Finardi G. Mitral valve prolapse in systemic lupus erythematosus. Clin Exp Rheumatol 1987; 5: 59-62.
7. Comens SM, Alpert MA, Sharp GC et al. Frequency of mitral valve prolapse in systemic lupus erythematosus. Progressive systemic sclerosis and mixed connective tissue disease. Am J Cardiol 1989; 63: 369.
8. Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995; 51: 117-126.
9. Leung W, Wong K, Lau C, Wong C, Liu H. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411-419.
10. Metz D, Jolly D, Gracier-Richard J et al. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 1994; 85: 129-136.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 271-277.
12. Kurata N, Tan EM. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19:574-580.
13. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
14. 2 glycoprotein I dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995; 172: 926-931.
15. Freed LA, Levy D, Levine RA et al. Prevalence and clinical outcome of mitral valve prolapse. New Engl J Med 1999; 341: 1-7.
16. Kalke S, Balakrishanan C, Mangat G, Mittal G, Kumar N, Joshi VR. Echocardiography in systemic lupus erythematosus. Lupus 1998; 7: 540-544.
17. Enomoto K et al. Frequency of valvular regurgitation by color doppler echocardiography in SLE. Am J Cardiol 1991; 67: 209-211.
18. Doherty NE III, Feldman G, Maurer G, Siegel RJ. Echocardiographic findings in systemic lupus erythematosus. Am J Cardiol 1988; 61: 1144.
19. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del Castillo H, Soler-Soler J. Prevalence, morphologic types and evolution of cardiac valvular disease in systemic lupus erythematosus. New Engl J Med 1988; 319: 817-823.
20. Klinkoff AV, Thompson CH, Reid GD, Tomlinson CW. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA 1985; 253: 3273-3277.
21. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. New Engl J Med 1996; 335: 1424-1430.
22. Chia BL, Mah EPR, Feng PH. Cardiovascular abnormalities in systemic lupus erythematosus. J Clin Ultrasound 1981; 9: 237-243.
23. Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992; 34: 69-74.
24. Bulkey BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 1975; 58: 243-264.
25. Garcia-Torres R, Amigo MC, de la Rosa A, Moron A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 1996; 5: 56-61.
26. Amital H, Langevitz P, Levy Y et al. Valvular deposistion of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol 1999; 17: 99-102.
27. Hojnick M, George J, Ziporen L, Shoenfeld Y. Heart valve Involvement (Libman - Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1999; 93: 1579-1587.
28. Khamashta MA, Cervera R, Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
29. Gleason CB, Stoddard M, Stephen G, Longaker RA, Pirangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993; 125: 1123-1129.
30. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus, association with raised anticardiolipin antibodies. Circulation 1990; 82: 369-374.
31. Nogima J, Suehisa E, Akita N et al. Risk of arterial thrombosis in patients with aCL and lupus anticoagulant. Br J Hematol 1997; 96: 447-450.
32. 2 glycoprotein I antibodies in patients with Systemic Lupus Erythematosus and Systemic Sclerosis - clinical significance. Immunol Lett 1997; 1-3: P.5.21.08.
33. Ford PM. The immunology of aging. Clin Rheum Dis 1986; 12: 1-10.
34. Kausman D, Isenbeg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol 1995; 34: 361-364.
35. Gordon T, Isenberg D. Organ specific and multisystemic autoimmune disease. Part of a spectrum which may coexist in the same patient. Clin Rheumatol 1990; 9: 401-403.
36. Evangelopoulou ME, Alevizaki M, Toumanidis S et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? Thyroid 1999; 9: 973-977.
37. Shah NM, Khamashta MA, Atsumi T, Hughes GRV. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 1998; 7: 3-6.